These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9141210)

  • 1. Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity.
    Baldridge JR; Ward JR
    Vaccine; 1997 Mar; 15(4):395-401. PubMed ID: 9141210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction by killed Listeria monocytogenes of effector T cells mediating delayed-type hypersensitivity but not protection in mice.
    Koga T; Mitsuyama M; Handa T; Yayama T; Muramori K; Nomoto K
    Immunology; 1987 Oct; 62(2):241-8. PubMed ID: 2445666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the adjuvant activity of naloxone, an opioid receptor antagonist, in combination with heat-killed Listeria monocytogenes vaccine.
    Jazani NH; Karimzad M; Mazloomi E; Sohrabpour M; Hassan ZM; Ghasemnejad H; Roshan-Milani S; Shahabi S
    Microbes Infect; 2010 May; 12(5):382-8. PubMed ID: 20152926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed-type hypersensitivity and acquired cellular resistance in mice immunized with killed Listeria monocytogenes and adjuvants.
    Van Der Meer C; Hofhuis FM; Willers JM
    Immunology; 1979 May; 37(1):77-82. PubMed ID: 112043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route.
    Ravindran R; Maji M; Ali N
    Mol Pharm; 2012 Jan; 9(1):59-70. PubMed ID: 22133194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the immunogenicity and protective efficacy of killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis.
    Thakur A; Kaur H; Kaur S
    Med Microbiol Immunol; 2015 Aug; 204(4):539-50. PubMed ID: 25432859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-bacterial immunity to Listeria monocytogenes in allogeneic bone marrow chimera in mice.
    Onoé K; Good RA; Yamamoto K
    J Immunol; 1986 Jun; 136(11):4264-9. PubMed ID: 2871109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen Listeria monocytogenes.
    Rolph MS; Kaufmann SH
    J Immunol; 2001 Apr; 166(8):5115-21. PubMed ID: 11290793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.
    Schafer R; Portnoy DA; Brassell SA; Paterson Y
    J Immunol; 1992 Jul; 149(1):53-9. PubMed ID: 1607662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune privilege in the anterior chamber of the eye is not extended to intraocular Listeria monocytogenes.
    Li XY; Niederkorn JY
    Ocul Immunol Inflamm; 1997 Dec; 5(4):245-57. PubMed ID: 9455741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cell wall skeleton and monophosphoryl lipid A adjuvant on the immunogenicity of a murine B16 melanoma vaccine.
    Johnston D; Bystryn JC
    J Natl Cancer Inst; 1991 Sep; 83(17):1240-5. PubMed ID: 1870150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells.
    Okamoto S; Kawabata S; Nakagawa I; Hamada S
    Infect Immun; 2001 Nov; 69(11):6633-42. PubMed ID: 11598032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killed Listeria-induced suppressor T cells involved in suppression of delayed-type hypersensitivity and protection against Listeria infection.
    Yamamoto K; Kato K; Kimura T
    Immunology; 1985 Aug; 55(4):609-19. PubMed ID: 2410356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
    Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
    Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lived protective immunity to Listeria is conferred by immunization with particulate or soluble listerial antigen preparations coadministered with IL-12.
    Miller MA; Skeen MJ; Ziegler HK
    Cell Immunol; 1998 Mar; 184(2):92-104. PubMed ID: 9630835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice.
    Zimecki M; Kruzel ML
    Immunol Lett; 2000 Nov; 74(3):183-8. PubMed ID: 11064098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Cell Wall-Deficient Spheroplasts Against Experimental Murine Listeriosis.
    Ansari MA; Zia Q; Kazmi S; Ahmad E; Azhar A; Johnson KE; Zubair S; Owais M
    Scand J Immunol; 2015 Jul; 82(1):10-24. PubMed ID: 25833403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.
    Rodriguez-Del Rio E; Marradi M; Calderon-Gonzalez R; Frande-Cabanes E; Penadés S; Petrovsky N; Alvarez-Dominguez C
    Vaccine; 2015 Mar; 33(12):1465-73. PubMed ID: 25659269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of both protection and delayed-type hypersensitivity against live Listeria is mediated by the CD8+ T cell subset: a study with Listeria-specific T lymphocytes recovered from murine infected liver.
    Goossens PL; Marchal G; Milon G
    Int Immunol; 1992 May; 4(5):591-8. PubMed ID: 1627496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.